For a successful global commercialization strategy, these challenges need strategic planning early in the development process. Tissue availability is a major bottleneck in CDx development.
We are very pleased with our collaboration with Innoviva Specialty Therapeutics for the commercialization of Zevtera in the US. The company is a highly committed, focused and capable partner that ...